Modul 3A - for somatic cell therapies, biotechnology-engineered tissue products (except for bone marrow or peripheral blood stem cell preparations, which are not substantially processed and intended for non-homologous use) and gene therapy

date of issue 21.04.2011

file

• file "Modul 3A - for somatic cell therapies, biotechnology-engineered tissue products (except for bone marrow or peripheral blood stem cell preparations, which are not substantially processed and intended for non-homologous use) and gene therapy"download(PDF, 285KB, File does not meet accessibility standards.)